Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-090192
Filing Date
2025-06-26
Accepted
2025-06-26 08:30:06
Documents
1
Period of Report
2025-06-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3174
  Complete submission text file 0000950170-25-090192.txt   4746
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O SIGA TECHNOLOGIES, INC. 31 EAST 62ND STREET NEW YORK NY 10065
Business Address
Nabel Gary J. (Reporting) CIK: 0001867450 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 251075151